{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:07:44Z","timestamp":1769562464749,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer New York","isbn-type":[{"value":"9781493936137","type":"print"},{"value":"9781493936151","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3615-1_4","type":"book-chapter","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T09:27:25Z","timestamp":1464946045000},"page":"59-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma"],"prefix":"10.1007","author":[{"given":"Sarah S.","family":"Burns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,4]]},"reference":[{"key":"4_CR1","volume-title":"Advances in neurofibromatosis research","author":"C Yates","year":"2011","unstructured":"Yates C, Welling DB, Chang L-S (2011) Research advances in therapeutics for neurofibromatosis type 2-associated vestibular schwannomas. In: Cunha KS, Geller M (eds) Advances in neurofibromatosis research. Nova Science Publishers, Inc., Hauppauge, NY"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314","journal-title":"J Neurooncol"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/342716","volume":"71","author":"ME Baser","year":"2002","unstructured":"Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG (2002) Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71:715\u2013723","journal-title":"Am J Hum Genet"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","volume":"99","author":"S Goutagny","year":"2010","unstructured":"Goutagny S, Kalamarides M (2010) Meningiomas and neurofibromatosis. J Neurooncol 99:341\u2013347","journal-title":"J Neurooncol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 363:515\u2013521","journal-title":"Nature"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL et al (1993) A novel Moesin-, Exrin-, Radixin-like gene is a candidate for the neurofibromatosis 2 tumor-suppressor. Cell 72:791\u2013800","journal-title":"Cell"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng0294-185","volume":"6","author":"AB Bianchi","year":"1994","unstructured":"Bianchi AB, Hara T, Ramesh V et al (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6:185\u2013192","journal-title":"Nat Genet"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","volume":"92","author":"AB Bianchi","year":"1995","unstructured":"Bianchi AB, Mitsunnaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci U S A 92:10854\u201310858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","volume":"14","author":"M Giovannini","year":"2000","unstructured":"Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M et al (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617\u20131630","journal-title":"Genes Dev"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/onc.2010.609","volume":"30","author":"M Kalamarides","year":"2011","unstructured":"Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, Martinelli C, Lusis EA, Hegedus B, Gutmann DH, Giovannini M (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30:2333\u20132344","journal-title":"Oncogene"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddu414","volume":"24","author":"JR Gehlhausen","year":"2015","unstructured":"Gehlhausen JR, Park SJ, Hickox AE et al (2015) A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. Hum Mol Genet 24:1\u20138","journal-title":"Hum Mol Genet"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/01.mlg.0000240185.14224.7d","volume":"116","author":"L-S Chang","year":"2006","unstructured":"Chang L-S, Jacob A, Lorenz M, Rock J et al (2006) Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice. Laryngoscope 116:2018\u20132026","journal-title":"Laryngoscope"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/MAO.0b013e31818b6cea","volume":"30","author":"BA Neff","year":"2009","unstructured":"Neff BA, Voss SG, Allen C, Schroeder MA, Driscoll CL, Link MJ, Galanis E, Sarkaria JN (2009) Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD\/SCID mice. Otol Neurotol 30:105\u2013111","journal-title":"Otol Neurotol"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrclinonc.2013.144","volume":"10","author":"AL Lin","year":"2013","unstructured":"Lin AL, Gutmann DH (2013) Advances in the treatment of neurofibromatosis-associated tumours. Nat Rev Clin Oncol 10:616\u2013624","journal-title":"Nat Rev Clin Oncol"},{"key":"4_CR15","first-page":"135","volume":"2015","author":"Y Wang","year":"2015","unstructured":"Wang Y, Tseng JC, Sun Y, Beck AH, Kung AL (2015) Noninvasive imaging of tumor burden and molecular pathways in mouse models of cancer. Cold Spring Harb Protoc 2015:135\u2013144","journal-title":"Cold Spring Harb Protoc"},{"key":"4_CR16","unstructured":"Chang L-S, Welling DB (2009) Molecular biology of vestibular schwannomas. In: Sokolowski B (ed) Auditory\/vestibular research, The Humana Press, Totowa, NJ, Methods Mol Biol 493:163\u2013177"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1097\/MAO.0b013e3182956169","volume":"34","author":"SA Spear","year":"2013","unstructured":"Spear SA, Burns SS, Oblinger JL, Ren Y, Pan L, Kinghorn AD, Welling DB, Chang L-S (2013) Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide. Otol Neurotol 34:1519\u20131527","journal-title":"Otol Neurotol"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S P\u00fcttmann","year":"2005","unstructured":"P\u00fcttmann S, Senner V, Braune V, Hillmann B, Exeler R, Rickert C et al (2005) Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 85: 1163\u20131171","journal-title":"Lab Invest"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/0008-5472.CAN-12-1888","volume":"73","author":"SS Burns","year":"2013","unstructured":"Burns SS, Akhmametyeva EA, Oblinger JL, Bush ML, Huang J, Senner V, Chen C-S, Jacob A, Welling DB, Chang L-S (2013) AR-42, a histone deacetylase inhibitor, differentially affects cell-cycle progression of meningeal and meningioma cells and potently inhibits NF2 \u2013 meningioma growth. Cancer Res 73:792\u2013803","journal-title":"Cancer Res"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"14342","DOI":"10.1073\/pnas.0804105105","volume":"105","author":"BA Rabinovich","year":"2008","unstructured":"Rabinovich BA, Ye Y, Etto T, Chen JQ, Levitsky HI, Overwijk WW, Cooper LJ, Gelovani J, Hwu P (2008) Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A 105:14342\u201314346","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"e9364","DOI":"10.1371\/journal.pone.0009364","volume":"5","author":"JB Kim","year":"2010","unstructured":"Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, Bata A, Campbell K, Coffee R, Gorodinsky A, Lu Z, Zhou H, Kishimoto TK, Lassota P (2010) Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 5:e9364","journal-title":"PLoS One"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.chembiol.2011.09.019","volume":"18","author":"KR Harwood","year":"2011","unstructured":"Harwood KR, Mofford DM, Reddy GR, Miller SC (2011) Identification of mutant firefly luciferases that efficiently utilize aminoluciferins. Chem Biol 18:1649\u20131657","journal-title":"Chem Biol"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbpa.2009.11.001","volume":"14","author":"JA Prescher","year":"2010","unstructured":"Prescher JA, Contag CH (2010) Guided by the light: visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol 14:80\u201389","journal-title":"Curr Opin Chem Biol"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11307-009-0291-3","volume":"12","author":"L Mezzanotte","year":"2010","unstructured":"Mezzanotte L, Fazzina R, Michelini E, Tonelli R, Pession A, Branchini B, Roda A (2010) In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase. Mol Imaging Biol 12:406\u2013414","journal-title":"Mol Imaging Biol"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0301-4622(02)00057-1","volume":"97","author":"HE Davis","year":"2002","unstructured":"Davis HE, Morgan JR, Yarmush ML (2002) Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 97:159\u2013172","journal-title":"Biophys Chem"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0166-0934(89)90132-8","volume":"23","author":"K Cornetta","year":"1989","unstructured":"Cornetta K, Anderson WF (1989) Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods 23:187\u2013194","journal-title":"J Virol Methods"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7:118\u2013130","journal-title":"Nat Rev Immunol"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K et al (2002) NOD\/SCID\/\u03b3cnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175\u20133182","journal-title":"Blood"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1158\/1078-0432.CCR-08-2502","volume":"15","author":"BM Carreno","year":"2009","unstructured":"Carreno BM, Garbow JR, Kolar GR, Jackson EN, Engelbach JA, Becker-Hapak M, Carayannopoulos LN, Piwnica-Worms D, Linette GP (2009) Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases. Clin Cancer Res 15:3277\u20133286","journal-title":"Clin Cancer Res"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature03847","volume":"436","author":"S Kim","year":"2005","unstructured":"Kim S, Poursine-Laurent J, Truscott SM et al (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709\u2013713","journal-title":"Nature"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al (2005) Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477\u20136489","journal-title":"J Immunol"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nmeth.2839","volume":"11","author":"MS Evans","year":"2014","unstructured":"Evans MS, Chaurette JP, Adams ST Jr, Reddy GR, Paley MA, Aronin N, Prescher JA, Miller SC (2014) A synthetic luciferin improves bioluminescence imaging in live mice. Nat Methods 11:393\u2013395","journal-title":"Nat Methods"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-13-2971","volume":"74","author":"JL Wilding","year":"2014","unstructured":"Wilding JL, Bodmer WF (2014) Cancer cell lines for drug discovery and development. Cancer Res 74:2377\u20132384","journal-title":"Cancer Res"}],"container-title":["Methods in Molecular Biology","Auditory and Vestibular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3615-1_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T01:17:36Z","timestamp":1656638256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3615-1_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493936137","9781493936151"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3615-1_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"4 June 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}